Logo image
Sign in
Cost-Effectiveness of Glycoprotein IIb/IIIa Inhibitors in Diabetics with Non-STEMI ACS
Journal article   Peer reviewed

Cost-Effectiveness of Glycoprotein IIb/IIIa Inhibitors in Diabetics with Non-STEMI ACS

Daniel Hilleman, Tammy Burns, Dawn Knudsen, Stephanie Maciejewski and Antonio Reyes
Diabetes (New York, N.Y.), Vol.54, p.A512
06/01/2005

Metrics

1 Record Views

Details